Position in XNCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,194,191
+$3,480,814 QoQ
Shares Held
819,515
+1.7% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 208 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. XNCR ranks #73 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in XNCR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,194,191 | 819,515 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,713,377 | 805,421 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,114,363 | 268,737 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,382,580 | 629,376 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,457,165 | 439,843 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,246,593 | 305,131 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,830,184 | 297,223 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,448,422 | 469,837 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,495,553 | 501,614 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,267,222 | 599,513 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,401,284 | 395,727 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,547,371 | 225,676 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,288,421 | 211,791 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,328,747 | 191,063 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,466,418 | 133,119 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,292,423 | 88,238 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,429,234 | 52,219 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,623,897 | 98,347 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $730,463 | 21,179 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,824,236 | 42,365 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $1,041,435 | 32,153 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||